Cell-penetrating peptide conjugations and magnetic cell labels

Cell-Penetrating Peptides: Processes and Applications

Volumn , Issue , 2002, Pages 327-346

  Tung, Ching Hsuan ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037706494     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (63)

1. Dubowchik, G.M. and Walker, M.A., Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs, Pharmacol. Ther., 83, 67, 1999.
2. Reddy, J.A. and Low, P.S., Folate-mediated targeting of therapeutic and imaging agents to cancers, Crit. Rev. Ther. Drug Carrier Syst., 15, 587, 1998.
3. Marecos, E. et al., Antibody-mediated vs. nontargeted delivery in a human small cell lung carcinoma model, Bioconjug. Chem., 9, 184, 1998.
4. Rojas, M. et al., Genetic engineering of proteins with cell membrane permeability, Nat. Biotechnol., 16, 370, 1998.
5. Prochiantz, A., Messenger proteins: homeoproteins, TAT and others, Curr. Opin. Cell Biol., 12, 400, 2000.
6. Lindgren, M. et al., Cell-penetrating peptides, Trends Pharmacol. Sci., 21, 99, 2000.
7. Fawell, S. et al., Tat-mediated delivery of heterologous proteins into cells, Proc. Natl. Acad. Sci. U.S.A., 91, 664, 1994.
8. Vivés, E. et al., A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem., 272, 16010, 1997.
9. Derossi, D. et al., Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent, J. Biol. Chem., 271, 18188, 1996.
10. Pooga, M. et al., Cell penetration by transportan, FASEB. J., 12, 67, 1998.
11. Soomets, U. et al., Deletion analogues of transportan, Biochim. Biophys. Acta, 1467, 165, 2000.
12. Avrameas, A. et al., Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules, Proc. Natl. Acad. Sci. U.S.A., 95, 5601, 1998.
13. Phelan, A. et al., Intercellular delivery of functional p53 by the herpesvirus protein VP22, Nat. Biotechnol., 16, 440, 1998.
14. Elliott, G. and O’Hare, P., Intercellular trafficking and protein delivery by a herpesvirus structural protein, Cell, 88, 223, 1997.
15. Sheldon, K. et al., Loligomers: design of de novo peptide-based intracellular vehicles, Proc. Natl. Acad. Sci. U.S.A., 92, 2056, 1995.
16. Zhang, L. et al., Preparation of functionally active cell-permeable peptides by singlestep ligation of two peptide modules, Proc. Natl. Acad. Sci. U.S.A., 95, 9184, 1998.
17. Efthymiadis, A. et al., The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties, J. Biol. Chem., 273, 1623, 1998.
18. Pepinsky, R.B. et al., Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its repressor, DNA Cell Biol., 13, 1011, 1994.
19. Anderson, D.C. et al., Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide, Biochem. Biophys. Res. Commun., 194, 876, 1993.
20. Bayley, H., Protein therapy-delivery guaranteed, Nat. Biotechnol., 17, 1066, 1999.
21. Nagahara, H. et al., Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration, Nat. Med., 4, 1449, 1998.
22. Vocero-Akbani, A.M. et al., Killing HIV-infected cells by transduction with an HIV protease- activated caspase-3 protein, Nat. Med., 5, 29, 1999.
23. Pooga, M. et al., Cellular translocation of proteins by transportan, FASEB. J., 15, 1451, 2001.
24. Lin, Y.Z. et al., Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence, J. Biol. Chem., 270, 14255, 1995.
25. Schluesener, H.J., Protection against experimental nervous system autoimmune diseases by a human immunodeficiency virus-1 Tat peptide-based polyvalent vaccine, J. Neurosci. Res., 46, 258, 1996.
26. Morris, M.C. et al., A new peptide vector for efficient delivery of oligonucleotides into mammalian cells, Nucleic. Acids Res., 25, 2730, 1997.
27. Antopolsky, M. et al., Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties, Bioconjug. Chem., 10, 598, 1999.
28. Astriab-Fisher, A. et al., Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates, Biochem. Pharmacol., 60, 83, 2000.
29. Pooga, M. et al., Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo, Nat. Biotechnol., 16, 857, 1998.
30. Elliott, G. and O’Hare, P., Intercellular trafficking of VP22-GFP fusion proteins, Gene Ther., 6, 149, 1999.
31. Zhang, F. et al., A transfecting peptide derived from adenovirus fiber protein, Gene Ther., 6, 171, 1999.
32. Singh, D. et al., Peptide-based intracellular shuttle able to facilitate gene transfer in mammalian cells, Bioconjug. Chem., 10, 745, 1999.
33. Bhorade, R. et al., Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-Tat derived membrane translocation peptide, Bioconjug. Chem., 11, 301, 2000.
34. Lewin, M. et al., Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, Nat. Biotechnol., 18, 410, 2000.
35. Josephson, L. et al., High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates, Bioconjug. Chem., 10, 186, 1999.
36. Polyakov, V. et al., Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy, Bioconjug. Chem., 11, 762, 2000.
37. Ishii, Y. and Lehrer, S.S., Effects of the state of the succinimido-ring on the fluorescence and structural properties of pyrene maleimide-labeled alpha alpha-tropomyosin, Biophys. J., 50, 75, 1986.
38. Theodore, L. et al., Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse, J. Neurosci., 15, 7158, 1995.
39. Wender, P.A. et al., The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters, Proc. Natl. Acad. Sci. U.S.A., 97, 13003, 2000.
40. Mitchell, D.J. et al., Polyarginine enters cells more efficiently than other polycationic homopolymers, J. Pept. Res., 56, 318, 2000.
41. Futaki, S. et al., Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery, J. Biol. Chem., 276, 5836, 2001.
42. Shen, T. et al., Monocrystalline iron oxide nanocompounds (MION): physiocochemical propreties, Magn. Reson. Med., 29, 599, 1993.
43. Schulze, E. et al., Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro, Invest. Radiol., 30, 604, 1995.
44. Shen, T.T. et al., Magnetically labeled secretin retains receptor affinity to pancreas acinar cells, Bioconjug. Chem., 7, 311, 1996.
45. Moore, A. et al., Measuring transferrin receptor gene expression by NMR imaging, Biochim. Biophys. Acta, 1402, 239, 1998.
46. Schoepf, U. et al., Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies, BioTechniques, 24, 642, 1998.
47. Weissleder, R. et al., Magnetically labeled cells can be detected by MR imaging, J. Magn. Reson. Imaging, 7, 258, 1997.
48. Schoept, U. et al., Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies, Biotechniques, 24, 642, 1998.
49. Gius, D.R. et al., Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1, Cancer Res., 59, 2577, 1999.
50. Schwarze, S.R. et al., In vivo protein transduction: delivery of a biologically active protein into the mouse, Science, 285, 1569, 1999.
51. Vocero-Akbani, A. et al., Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death, Methods Enzymol., 322, 508, 2000.
52. Xia, H. et al., The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors, Nat. Biotechnol., 19, 640, 2001.
53. Eguchi, A. et al., Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells, J. Biol. Chem., 276, 26204, 2001.
54. Vivés, E. et al., Structure-activity relationship study of the plasma membrane translocating protential of a short peptide from HIV-1 Tat protein, Lett. Peptide Sci., 4, 429, 1997.
55. Torchilin, V.P. et al., TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors, Proc. Natl. Acad. Sci. U.S.A., 98, 8786, 2001.
56. Lindgren, M. et al., Translocation properties of novel cell penetrating transportan and penetratin analogues, Bioconjug. Chem., 11, 619, 2000.
57. Fenton, M. et al., The efficient and rapid import of a peptide into primary B and T lymphocytes and a lymphoblastoid cell line, J. Immunol. Methods, 212, 41, 1998.
58. Han, K. et al., Efficient intracellular delivery of GFP by homeodomains of Drosophila Fushi-tarazu and Engrailed proteins, Mol. Cells, 10, 728, 2000.
59. Troy, C.M. et al., Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway, J. Neurosci., 16, 253, 1996.
60. Allinquant, B. et al., Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro, J. Cell Biol., 128, 919, 1995.
61. Bisland, S.K. et al., Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles, Bioconjug. Chem., 10, 982, 1999.
62. Rojas, M. et al., Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor, J. Biol. Chem., 271, 27456, 1996.
63. Rothbard, J.B. et al., Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation, Nat. Med., 6, 1253, 2000.